Healthcare & Assistive
From da Vinci surgical systems to rehab exoskeletons and elder-care companions, robotics is reshaping healthcare. This section grades what works in the clinic vs the marketing.
Topics in Healthcare & Assistive
24 articles
An evidence-based assessment of the surgical robotics landscape, graded by shipping hardware first, pilot deployments second, and announcements last. Covers da Vinci, Hugo, Versius, instrumentation economics, clinical validation pathways, and India availability with approximate landed cost estimates.
A grounded assessment of shipping rehab exoskeletons, grading claims by hardware delivery and clinical validation. Covers ReWalk, Ekso Bionics, and Cyberdyne HAL, with independent reporting on efficacy, manufacturing status, and India availability with landed cost estimates.
A grounded assessment of shipping elder-care companions like ElliQ, Paro, and Lovot, graded by hardware availability, pilot deployments, and India import realities.
A grounded assessment of autonomous mobile robots deployed in hospital logistics, graded by actual shipping hardware over pilots and announcements. Covers Aethon TUG, Diligent Robotics Moxi, navigation architecture, integration constraints, and India availability with landed cost estimates.
An evidence-based assessment of da Vinci, Versius, and Hugo RAS in the soft-tissue surgical robotics space. Claims are graded by deployed units, independent clinical evaluations, and regulatory status, with explicit notes on India availability, CDSCO pathways, and approximate landed pricing.
An evidence-graded review of commercial rehab exoskeletons, focusing on ReWalk, Ekso, and Cyberdyne HAL hardware status, independent clinical outcomes, and realistic India availability with landed cost estimates.
A grounded assessment of commercially available elder-care robots, graded by deployment status and hardware readiness. Covers ElliQ, Paro, Lovot, and the technical and regulatory realities of deploying assistive home companions in India and global markets.
A grounded evaluation of commercial hospital AMRs, prioritizing shipped hardware over pilot claims, with technical specifications, deployment realities, and India market availability.
A deployment-graded assessment of the da Vinci, Hugo, and Versius surgical robot platforms, covering architecture, clinical validation, India procurement pathways, and landed cost estimates for soft-tissue minimally invasive surgery.
A hardware-first assessment of commercial rehab exoskeletons, grading ReWalk, Ekso Bionics, and Cyberdyne HAL by deployed units, regulatory status, and independent clinical outcomes, with explicit notes on India availability and approximate landed pricing.
A grounded assessment of ElliQ, Paro, and Lovot, graded by deployment status, technical limitations, maintenance requirements, and landed costs in India. The article separates shipping hardware from pilot deployments, reviews manufacturer specifications, and outlines regulatory and import realities for assistive home companions.
A hardware-first assessment of autonomous mobile robots (AMRs) for hospital logistics, focusing on Aethon TUG and Moxi. The article grades deployment maturity, reviews clinical workflow integration, examines India market availability, and provides landed cost estimates based on manufacturer specifications and independent procurement data.
An evidence-based assessment of the da Vinci, Hugo, and Versius surgical robot platforms, graded by commercial deployment status, technical specifications, and India availability.
A grounded assessment of commercial rehab exoskeletons—ReWalk, Ekso Bionics, and Cyberdyne HAL—analyzed by shipped hardware, clinical outcomes, deployment logistics, and India market availability.
A grounded evaluation of ElliQ, Paro, Lovot, and assistive home companions. This article grades claims by shipping hardware, pilot deployments, and announcements, examines clinical and commercial deployment data, and maps India availability, import duties, and landed cost estimates.
A grounded assessment of hospital autonomous mobile robots, focusing on Aethon TUG and Diligent Moxi. This article grades claims by verified deployments, details technical integration and safety protocols, and outlines India availability and landed cost estimates.
An evidence-based review of hospital autonomous mobile robots, grading claims by shipping hardware first, pilot deployments second, and announcements last. Focus on Aethon TUG and Diligent Moxi, their verified deployments, technical limitations, and India availability with landed cost estimates.
An evidence-based review of the da Vinci, Hugo, and Versius platforms, graded by actual shipping hardware and pilot deployments, with a focus on soft-tissue surgery capabilities, clinical limitations, and India availability.
A grounded assessment of shipping lower-extremity rehab exoskeletons, graded by commercial hardware status, clinical evidence quality, and India market availability. ReWalk, EksoGT, and Cyberdyne HAL hold regulatory clearance and are deployed in clinical settings, but independent studies show modest functional gains. Pricing and import pathways for India are detailed with landed cost estimates.
A grounded assessment of ElliQ, Paro, and Lovot against the broader assistive companion landscape, graded by deployment status, with explicit notes on India availability, landed costs, and regulatory pathways.
A hardware-first assessment of commercial rehab exoskeletons, grading EksoNR, ReWalk, and Cyberdyne HAL by verified deployments and peer-reviewed outcomes. Includes India availability, landed cost estimates, and implementation constraints.
A measured assessment of elder-care companion and assistive robots, graded by actual shipping hardware, verified pilot deployments, and commercial availability, with explicit notes on India import pathways and landed cost estimates.
A factual assessment of commercial hospital autonomous mobile robots, grading claims by shipped hardware and verified deployments. Covers Aethon TUG logistics platforms, Diligent Robotics Moxi workflow support, navigation and safety standards, integration realities, and India availability with landed cost estimates.
An evidence-based assessment of the commercial surgical robotics landscape, grading da Vinci, Hugo SRS, and Versius by verified shipping hardware, pilot deployments, and India availability. Pricing, regulatory pathways, and soft-tissue engineering constraints are evaluated without concept hype.